3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Abdominal Migraine

3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide has been researched along with Abdominal Migraine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ferrari, MD; Saxena, PR; van Royen, EA; Verhoeff, NP; Visser, WH	1

Other Studies

1 other study(ies) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Abdominal Migraine

Article	Year
Dopamine D2-receptor imaging with 123I-iodobenzamide SPECT in migraine patients abusing ergotamine: does ergotamine cross the blood brain barrier? Cephalalgia : an international journal of headache, 1993, Volume: 13, Issue:5 Topics: Benzamides; Blood-Brain Barrier; Brain; Contrast Media; Dopamine D2 Receptor Antagonists; Ergotamine; Female; Humans; Iodine Radioisotopes; Male; Middle Aged; Migraine Disorders; Pyrrolidines; Receptors, Dopamine D2; Substance Withdrawal Syndrome; Substance-Related Disorders; Tomography, Emission-Computed, Single-Photon	1993

Article

Year

Dopamine D2-receptor imaging with 123I-iodobenzamide SPECT in migraine patients abusing ergotamine: does ergotamine cross the blood brain barrier?

Cephalalgia : an international journal of headache, 1993, Volume: 13, Issue:5

Topics: Benzamides; Blood-Brain Barrier; Brain; Contrast Media; Dopamine D2 Receptor Antagonists; Ergotamine; Female; Humans; Iodine Radioisotopes; Male; Middle Aged; Migraine Disorders; Pyrrolidines; Receptors, Dopamine D2; Substance Withdrawal Syndrome; Substance-Related Disorders; Tomography, Emission-Computed, Single-Photon

1993